The Latest Cardiac and Vascular News
Supira’s technology features a novel low profile, high continuous flow design that aims to provide full hemodynamic support for high-risk percutaneous coronary interventions (HRPCI) and cardiogenic shock (CS) patients with a single device Data from the Company’s First-in-Human trial to […]
Company Appoints Seasoned Medtech Executive as President and CEO CAMPBELL, Calif., March 5, 2020 /PRNewswire/ — Supira Medical, formed by Shifamed as part of its medical innovation hub, announced today the closing of $35M in Series B financing. Officially closed on February 25, the financing was […]
CAMPBELL, Calif., June 13, 2018 /PRNewswire/ — Shifamed, LLC announced today the $15.5M financing of Supira Medical, the newest Shifamed portfolio company. The financing, led by The Capital Partnership (TCP) with participation from Cormorant Asset Management and Shifamed Angels, officially closed on April 25, 2018. Supira […]
